US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Noxopharm Limited (NOX) 銘柄情報

Noxopharm Limited (NOX)

0.086

0.001

( 1.18% )

更新日時： 11:34:13

Noxopharm Limited (NOX) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.086

( 1.18% )

買値

0.081

売値

0.085

出来高

224,853

0.077 日の範囲 0.086

0.043 52 週間の範囲 0.135

時価総額

前日終値

0.085

始値

0.077

時刻

最終取引時間

10:58:18

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 194,567

発行済株式数

307,237,950

配当利回り

PER

-4.31

1 株当たり利益 (EPS)

-0.02

歳入

3.4M

純利益

-5.49M

Noxopharm Limited, a biotech company, engages in the discovering and developing treatments for cancer and inflammation, and mRNA vaccines in Australia. It develops Sofra, a platform that focuses on the development of immunomodulators for mRNA vaccines and mRNA therapeutics, as well as for the treatm... Noxopharm Limited, a biotech company, engages in the discovering and developing treatments for cancer and inflammation, and mRNA vaccines in Australia. It develops Sofra, a platform that focuses on the development of immunomodulators for mRNA vaccines and mRNA therapeutics, as well as for the treatment of autoimmune diseases; and Chroma technology platform to develop CRO-67 dual-cell therapy drug for the treatment of pancreatic cancer and various molecules for the treatment of autoimmune disease and hyperinflammatory conditions. The company also develops orphan drug designations to treat less common disease; and IONIC program with Veyonda, which is combined with the Bristol Myers Squibb checkpoint inhibitor Opdivo for the treatment of various solid tumor types. The company was incorporated in 2015 and is based in Glenhaven, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.noxopharm.com

本社

Glenhaven, Australia

設立

2026

Noxopharm Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker NOX. The last closing price for Noxopharm was AUD0.09. Over the last year, Noxopharm shares have traded in a share price range of AUD 0.043 to AUD 0.135.

Noxopharm currently has 307,237,950 shares in issue. The market capitalisation of Noxopharm is AUD26.42 million. Noxopharm has a price to earnings ratio (PE ratio) of -4.31.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.001	1.17647058824	0.085	0.086	0.071	495174	0.07504625	DE
4	0.019	28.3582089552	0.067	0.095	0.06	380427	0.08007125	DE
12	0.026	43.3333333333	0.06	0.095	0.051	208688	0.07523265	DE
26	-0.002	-2.27272727273	0.088	0.099	0.051	182932	0.07451728	DE
52	0.018	26.4705882353	0.068	0.135	0.043	191902	0.082242	DE
156	0.042	95.4545454545	0.044	0.165	0.033	276141	0.08721489	DE
260	-0.599	-87.4452554745	0.685	0.805	0.033	303587	0.19294235	DE

NOX - Frequently Asked Questions (FAQ)

What is the current Noxopharm Limited share price?

The current share price of Noxopharm Limited is AUD 0.086

How many Noxopharm Limited shares are in issue?

Noxopharm Limited has 307,237,950 shares in issue

What is the market cap of Noxopharm Limited?

The market capitalisation of Noxopharm Limited is AUD 26.42M

What is the 1 year trading range for Noxopharm Limited share price?

Noxopharm Limited has traded in the range of AUD 0.043 to AUD 0.135 during the past year

What is the PE ratio of Noxopharm Limited?

The price to earnings ratio of Noxopharm Limited is -4.31

What is the cash to sales ratio of Noxopharm Limited?

The cash to sales ratio of Noxopharm Limited is 7.33

What is the registered address of Noxopharm Limited?

The registered address for Noxopharm Limited is 60 Linksley Avenue, Glenhaven, New South Wales, 2156

What is the Noxopharm Limited website address?

The website address for Noxopharm Limited is www.noxopharm.com

Which industry sector does Noxopharm Limited operate in?

Noxopharm Limited operates in the Biotechnology & Life Sciences sector

Steady_T

Steady_T 4分前

In that case quit giving advice that you won't follow yourself.

Power of Emouna

Power of Emouna 7分前

Where's the BIG NEWS?! LoL 😂

zerosnoop

zerosnoop 8分前

The scare campaign by the PAID BASHERS & NAKED SHORT SELLERS is failing. Smart & educated investors aren't believing the LIES & NONSENSE being told by the NAKED SHORT SELLERS.

Why do these PAID BASHERS & NAKED SHORT SELLERS want to hang around like a bad smell unless they have an agen

sloppyjones

sloppyjones 8分前

A thought came to me. Maybe we are only seeing the free side to the app? I wonder if the rest of capabilities have just been turned off for now until they release the subscription model?
Notice how there isn't even an option to pay for a plan. I have a feeling that will be here soon and

barnstormer

barnstormer 17分前

Lolo, if you'll actually do some checking, I believe you'll find the FDA real world data issue is just someone's opinion as is the claim the FDA currently requires a closed system. Don't believe me, look it up it yourself.

joe botts

joe botts 28分前

Lol!!! So call Wertheim let me know how that goes? Lmao

sloppyjones

sloppyjones 29分前

This sounds promising!
https://www.linkedin.com/posts/jean-marc-herbet-97b4237a_vumelive-vumehongkong-worldcup2026-share-7470300813957971968-1a26/?utm_source=share&utm_medium=member_android&rcm=ACoAAAm5fn0BNNCgxoNsCsVMeAJ5eEU9hqPLf74

1kgwxman

1kgwxman 30分前

Why are you asking an investor for something only AMFN can provide?
If AMFN is too risky, then don't buy.
Penny stocks are risky.
Or wait until autumn and you'll have your answers.
I'm using gambling funds, so I'm fine with that risk.

Geez man...

NoMoDo

NoMoDo 32分前

I firmly believe that RWAX has incredible potential to be a great company. Not there yet, but potential. I want to provide my opinions on the company, both positive and negative, but I have decided that I won't post on Ihub again until my posting restrictions have been removed. I don't expect tha

surfkast

surfkast 32分前

Legal charges for what? 🤣

surfer44

surfer44 35分前

Offshore oil is booming. So are the Chinese companies that make the equipment for it.

https://youtu.be/9Xhr_Wdzej4

govprs

govprs 36分前

I’m with you dog! I like under .02 and been quietly adding 20-40k at a time. I have no consistency i just place the chips on the table now and then waiting for the deal come round.
Patience is so important I tell myself 😂😎
Good luck to all the good guys and gals on th

surfkast

surfkast 38分前

Claims of cancer which knows no age.

weedtrader420

weedtrader420 39分前

EVERLONG XRP 👊FOO FIGHTERS TIME LIKE THESE $100 target let them drop it a lot of money sitting on the sideline waiting to come in🤑

surfkast

surfkast 39分前

I have been saying that for months. When I saw he was not racing I looked up his horses. Many were gone from his stable . Sadly he spent a million on just three horses when he started his shell games.

europa7

europa7 40分前

EU Digital Product Passport Impact on US Supply Chains
"...DPPs begin in 2027, requiring standardized identifiers, secure data systems, and lifecycle tracking for goods sold in European markets..."
April 30, 2026
https://www.packagingdigest.com/regulations-standards/eu-digital-p

DredLock

DredLock 43分前

Craig Marshak is now officially the CEO of Wertheim & Co. Craig was named 'CEO' of GBT only because GBT will transition into Wertheim & Co. with Craig Marshak as CEO. GBT will be history. Patrick is interim CEO because soon GBT will become Wertheim and there will be no need for Patrick. Joe Botts,

Helter Skelter

Helter Skelter 45分前

But I do care 😺 about
$1,000,000,000 hitting our bottom line!

BB is estimated to earn ~18¢ for FY 2027.

585M OS / .18 = $105,000,000 profit for 2027.

I'm looking forward to Malikie adding $100 million to our
bot

King-of-Huns

King-of-Huns 46分前

I did a bit DD on how & when companies needs to file even if they are on Xpert

randychub

randychub 48分前

Gemini says basically the same thing - PFE will successfully argue for a heavily discounted royalty rate (1.5 to 2%) for 2022. They will leverage the factors to prove that the immense revenue was driven by Pfizer's unprecedented global manufacturing scale and risk-taking during a public health em

porty

I haven’t seen any gvsi communications. What were they? I see srnw had a 600,000 share update today on otcmarkets.

tdbowieknife

tdbowieknife 52分前

With the science of fusion you don't go to working fusion first try.... Where are the papers for the previous "prototypes"???

Geeezzz man...

.

.

Watch your wallet

Buyer Beware
Social Media Prom

EarningsCentral

EarningsCentral 53分前

Lolo_Ferrari

Lolo_Ferrari 57分前

Britain is not socialist 😂😂😂 Thatcher decentralized government control in the 80s. Clueless 🤦🏻

The FDA won't even entertain our trial data in its current form, a least the Communist States of the British Isles is looking at it. 🤣

Vontobel Financial Produ...

Euronext G Orange 060624...

Mid Wynd International I...

Coloured Ties Capital (PK)

FlexShares Trust

Acc Call Nts 19sep2047

Ubs (irl) Etf Plc - Msci...

Digital Intrepid Holding...

Invesco FTSE-All World U...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。